Indian Diagnostic Services Market Outlook 2020 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Indian Diagnostic Services Market Outlook 2020" report to their offering.

According to the new research report Indian Diagnostic Services Market Outlook 2020, the diagnostic services market is expected to continue growing at 27.5% for next five years. This growth is likely to be driven by improving healthcare facilities, medical diagnostic and pathological laboratories, private-public projects, and the health insurance sector. Moreover, with the rise in health consciousness in the society and the rising burden of chronic diseases, this market will swell to approximately INR 860 Billion in revenues market by 2020.

This present report provides an overview of the Indian diagnostic lab services market delivering an effective overview of the market size and future forecast. In terms of services, the market is dominated by pathology services, which account for approximately 70% of the market. The report additionally investigates the current market trends and opportunities with their impact on the performance of the sector. Further, the report provides consumer behavior patterns with respect to diagnostic services. Moreover, the report also provides insights regarding the prevalence and incidences of various diseases for which the diagnostic services are widely used.

The report also covers various business models in the Indian diagnostic services market, which generally scale up the level of diagnostic services and facilitate the entry of new market players. The report effectively assesses the implementation of commonly used models, such as PPP model, hub and spoke models, and even analyzes their impact in generating revenue. Moreover, industry experts prudently analyzed the regulatory and accreditation landscape with respect to setting up of diagnostic labs in Indian cities. The report, in this context, investigates into the viability of accrediting such diagnostics labs.

Key Topics Covered:

1. Analyst View

2. Research Methodology

3. India: Macro and Demographic Indicators

3.1 Healthcare Spending

3.2 Healthcare Infrastructure

3.3 Huge Population Base

4. Market Dynamics

4.1 Drivers

4.1.1 Rising Demand of Preventive Care Diagnostics

4.1.2 Rising Burden of Chronic Diseases

4.1.3 Public - Private Partnership Models for Promoting Diagnostic Services

4.1.4 Increasing Disposable Income

4.2 Challenges

4.2.1 Low Adoption of Advanced In-Vitro Diagnostic Technologies

4.2.2 Lack of Proper Regulatory Framework

4.3 Opportunities

4.3.1 Increasing Investment by Foreign Companies

4.3.2 Rise in Medical Tourism

4.3.3 Tele-radiology: Prospective Service Facilitator for Remote Areas

4.3.4 Emerging Tier II and Tier III cities

4.4 Trends

4.4.1 Increasing Automation Driving the Indian Diagnostic Services Market

4.4.2 Inclination of Doctors towards Debt Financing

4.4.3 Home Care Health Accessibility: Gaining Consumer Acceptance

4.4.4 E-packages: New Way to Deliver Diagnostic Services

4.4.5 Gene Based Testing Methods on the Rise

5. Disease Burden

5.1 Cancer

5.2 Cardiovascular Diseases

5.3 Tuberculosis

5.4 Malaria


5.6 Diabetes Mellitus

5.7 Dengue

6. Diagnostic Services Market: Current and Future Analysis

6.1 Pathology Services

6.2 Radiology Services

7. Diagnostic Services Market: Opportunity Assessment

7.1 Diagnostics Laboratories: Urban and Rural Split

7.2 Cost Assessment of Tests: Tier I and Tier II

7.3 PE Investment Landscape

8. Diagnostic Services: Business Models

8.1 Public Private Partnership (PPP)

8.1.1 Understanding of Concept: Indian Scenario

8.1.2 PPP Model in Healthcare and Diagnostic Services

8.1.3 Key Healthcare and Diagnostics PPP Projects

8.1.4 Case Study

8.2 Single Specialty Model (SSM)

8.2.1 Understanding the Concept: Indian Scenario

8.2.2 Model's Key Advantages

8.2.3 Case Study

8.3 Hub and Spoke Model

8.3.1 Understanding of Concept: Indian Scenario

8.3.2 Model's Key Advantages

8.3.3 Case Study

9. Consumer Behavior Research in Tier I and II

9.1 Tier I: Spending Aggressively on Diagnostic Tests

9.2 Physicians' Referred Labs Given Highest Preference

9.3 Brand Popularity: Key Determinant for Lab Preference

9.4 Independent Labs: Popular Among Respondents

9.5 Private Lab Facilities Dominating Government Owned Centers

9.6 Medium Scale Labs: Current Choice of the Respondents

10. Regulatory Environment: Accreditation and Quality Assurance

10.1 Requirements for the Shop and Establishment Act

10.2 NABL Accreditation Mandates

10.3 NABL Accreditation Procedure

10.4 Plausible Impact of the Clinical Establishments Act, 2010

11. Competitive Landscape (Business Overview, and Strength-Weakness Analysis)

11.1 Super Religare Laboratories

11.2 Dr. Lal PathLabs

11.3 Metropolis Healthcare Limited

11.4 Thyrocare Technologies Limited

11.5 Quest Diagnostics India Private Limited,

11.6 PathCare Labs Pvt. Ltd.

11.7 Oncquest Laboratories Ltd.

For more information visit


Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Diagnostics


Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Diagnostics